Cahill Thomas 4
4 · Prime Medicine, Inc. · Filed Jun 16, 2023
Insider Transaction Report
Form 4
Cahill Thomas
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-14+39,062→ 39,062 totalExercise: $14.83Exp: 2033-06-14→ Common Stock (39,062 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in full upon the earlier of (i) June 14, 2024 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.